Prognostic Value of Combination of Pretreatment Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Gastric Cancer

Abstract EN

Aims.

Gastric cancer (GC) is often diagnosed at an advanced stage; inexpensive and valid biomarkers for GC are still unavailable.

We aimed to evaluate the prognosis of the combination of pretreatment red cell distribution width (RDW) and neutrophil-to-lymphocyte ratio (NLR) in patients with GC.

Methods.

A retrospective analysis from 103 GC patients who were diagnosed at our institution from 2012 to 2016 was performed.

Both pretreatment RDW and NLR were calculated based on the recommended cutoff values of 13.4% and 2.755, respectively.

Combined values of RDW and NLR (RDW + NLR) stratified patients into a score of 0 (RDW ≤ 13.4% and NLR ≤ 2.755), a score of 1 (RDW > 13.4% or NLR > 2.755), and a score of 2 (RDW > 13.4% and NLR > 2.755).

Prognostic significances for overall survival (OS) and progression-free survival (PFS) were assessed.

Results.

Pretreatment RDW + NLR was a significantly independent prognostic factor for OS and PFS.

Moreover, high RDW + NLR was strongly related to age, tumor location, TNM stage, CA125, and CA199.

In a subgroup analysis for patients with advanced gastric cancer (AGC), we observed that the level of RDW + NLR was markedly associated with OS and PFS.

Conclusion.

Pretreatment RDW + NLR is a simple, inexpensive, and valid prognostic system to predict the survival in patients with GC, especially AGC.